Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Effects of comorbid alcohol use disorder on the clinical outcomes of first-episode schizophrenia: a nationwide population-based study

Variable

Schizophrenia with AUD (n = 1598)

Matched controls (n = 1598)

p-value

Onset age for schizophrenia, mean (SD), years

44.3 (12.2)

44.2 (12.4)

0.873

Onset age for comorbid AUD, mean (SD), years

46.1 (12.1)

NA

 

Sex, n (%)

1.000

 Male

1200 (75.1)

1199 (75.0)

 

 Female

398 (24.9)

399 (25.0)

 

Observation period, mean (SD), years

5.1 (2.5)

5.1 (2.5)

0.941

Total duration of antipsychotic treatment, mean (SD), years

2.6 (2.2)

3.5 (2.5)

< 0.001

Duration of the first antipsychotic treatment, mean (SD), days

202.6 (337.8)

344.0 (507.9)

< 0.001

Number of antipsychotic drugs in the total observation period, mean (SD)

4.0 (2.0)

3.4 (1.9)

< 0.001

Number of the treatment discontinuationsa in the total observation period, mean (SD)

3.4 (3.0)

2.6 (2.9)

< 0.001

  1. AUD alcohol use disorder, SD standard deviation, NA not applicable
  2. aDefined as no antipsychotic prescription within 28 days from the expected date of the next prescription